Stimulating beta cell replication and improving islet graft function by GPR119 agonists.

作者: Jie Gao , Lei Tian , Guobin Weng , Nicholas V. Bhagroo , Robert L. Sorenson

DOI: 10.1111/J.1432-2277.2011.01332.X

关键词: InsulinAgonistIsletMedicineReceptorBeta cellOleoylethanolamideInternal medicineTransplantationEndocrinologyIn vivo

摘要: G protein-coupled receptor 119 (GPR119) is predominantly expressed in β cells and intestinal L cells. In this study, we investigated whether oleoylethanolamide (OEA), a GPR119 endogenous ligand, PSN632408, synthetic agonist, can stimulate β-cell replication vitro vivo improve islet graft function diabetic mice. We found that OEA PSN632408 significantly increased numbers of insulin(+)/5-bromo-2'-deoxyuridine (BrdU)(+) cultured mouse islets dose-dependent manner. All recipient mice, given marginal syngeneic transplants with or vehicle, achieved normoglycemia at 4 weeks after transplantation. However, was faster OEA- PSN632408-treated mice than vehicle-treated (P < 0.05). The percentage insulin(+)/BrdU(+) grafts higher 0.01). Our data demonstrated function. Targeting novel therapeutic approach to increase mass by stimulating replication.

参考文章(38)
Unmesh Shah, GPR119 agonists: a promising new approach for the treatment of type 2 diabetes and related metabolic disorders. Current Opinion in Drug Discovery & Development. ,vol. 12, pp. 519- 532 ,(2009)
Hui J. Zhang, David E. R. Sutherland, Jeffrey A. Bluestone, Bernhard J. Hering, Raja Kandaswamy, James V. Harmon, Jeffrey D. Ansite, Sue M. Clemmings, Tetsuya Sakai, Stephen Paraskevas, Peter M. Eckman, Junichiro Sageshima, Masahiko Nakano, Toshiya Sawada, Ippei Matsumoto, Transplantation of Cultured Islets from Two-Layer Preserved Pancreases in Type 1 Diabetes with Anti-CD3 Antibody American Journal of Transplantation. ,vol. 4, pp. 390- 401 ,(2004) , 10.1046/J.1600-6143.2003.00351.X
Baolin Liu, Jianqiang Hao, Yisheng Pan, Bin Luo, Britt Westgard, Yves Heremans, David E. R. Sutherland, Bernhard J. Hering, Zhiguang Guo, Increasing donor chimerism and inducing tolerance to islet allografts by post-transplant donor lymphocyte infusion. American Journal of Transplantation. ,vol. 6, pp. 933- 946 ,(2006) , 10.1111/J.1600-6143.2006.01283.X
Y.-T. Zhou, M. Shimabukuro, M.-Y. Wang, Y. Lee, M. Higa, J. L. Milburn, C. B. Newgard, R. H. Unger, Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 8898- 8903 ,(1998) , 10.1073/PNAS.95.15.8898
N. A. Turgeon, J. G. Avila, J. A. Cano, J. J. Hutchinson, I. R. Badell, A. J. Page, A. B. Adams, M. H. Sears, P. H. Bowen, A. D. Kirk, T. C. Pearson, C. P. Larsen, Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation American Journal of Transplantation. ,vol. 10, pp. 2082- 2091 ,(2010) , 10.1111/J.1600-6143.2010.03212.X
Lei Tian, Jie Gao, Guangbin Weng, Huimin Yi, Bole Tian, Timothy D. O’Brien, Zhiguang Guo, Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts. Transplant International. ,vol. 24, pp. 856- 864 ,(2011) , 10.1111/J.1432-2277.2011.01275.X
Noel G. Morgan, Shalinee Dhayal, G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell. Biochemical Pharmacology. ,vol. 78, pp. 1419- 1427 ,(2009) , 10.1016/J.BCP.2009.07.020
Jin Fu, Silvana Gaetani, Fariba Oveisi, Jesse Lo Verme, Antonia Serrano, Fernando Rodríguez de Fonseca, Anja Rosengarth, Hartmut Luecke, Barbara Di Giacomo, Giorgio Tarzia, Daniele Piomelli, Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α Nature. ,vol. 425, pp. 90- 93 ,(2003) , 10.1038/NATURE01921
T. C. Brelje, J. A. Parsons, R. L. Sorenson, Regulation of islet β-cell proliferation by prolactin in rat islets Diabetes. ,vol. 43, pp. 263- 273 ,(1994) , 10.2337/DIAB.43.2.263
Kirstine Juhl, Susan Bonner-Weir, Arun Sharma, Regenerating pancreatic β-cells: plasticity of adult pancreatic cells and the feasibility of in-vivo neogenesis Current Opinion in Organ Transplantation. ,vol. 15, pp. 79- 85 ,(2010) , 10.1097/MOT.0B013E3283344932